Published in J Med Chem on May 01, 1988
Copper(II)-Catalyzed Aminooxygenation and Carboamination of N-Aryl-2-allylanilines. Adv Synth Catal (2009) 0.94
Dehydrogenation of the indoline-containing drug 4-chloro-N-(2-methyl-1-indolinyl)-3-sulfamoylbenzamide (indapamide) by CYP3A4: correlation with in silico predictions. Drug Metab Dispos (2008) 0.88
Discovery of 8-methoxypyrazino[1,2-a]indole as a New Potent Antiproliferative Agent Against Human Leukemia K562 Cells. A Structure-Activity Relationship Study. Lett Drug Des Discov (2009) 0.75
Brief intervention for harm reduction with alcohol-positive older adolescents in a hospital emergency department. J Consult Clin Psychol (1999) 5.45
Selectivity of blocking agents for pre-and postsynaptic alpha-adrenoceptors. Br J Pharmacol (1977) 3.49
Adeno-associated virus autointerference. Virology (1979) 2.43
Studies on RX 781094: a selective, potent and specific antagonist of alpha 2-adrenoceptors. Br J Pharmacol (1983) 2.21
Bioavailability of terfenadine in man. Biopharm Drug Dispos (1981) 2.16
Analogues of beta-LPH61-64 possessing selective agonist activity at mu-opiate receptors. Eur J Pharmacol (1981) 2.14
Infusion of alpha-galactosidase A reduces tissue globotriaosylceramide storage in patients with Fabry disease. Proc Natl Acad Sci U S A (2000) 2.00
Compilation of sequence-specific DNA-binding proteins implicated in transcriptional control in fungi. Nucleic Acids Res (1993) 1.98
High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infection. J Infect Dis (1995) 1.97
Suppression of plasma viral load below 20 copies/ml is required to achieve a long-term response to therapy. AIDS (1998) 1.81
BRG-1 is recruited to estrogen-responsive promoters and cooperates with factors involved in histone acetylation. Mol Cell Biol (2000) 1.80
Bacteremia due to Bordetella holmesii. Clin Infect Dis (1998) 1.79
Comparison of the SimPlate total plate count method with Petrifilm, Redigel, conventional pour-plate methods for enumerating aerobic microorganisms in foods. J Food Prot (1998) 1.74
Quantification of healthy follicles in the neonatal and adult mouse ovary: evidence for maintenance of primordial follicle supply. Reproduction (2006) 1.63
Central alpha- and beta-adrenoceptors modifying arterial blood pressure and heart rate in conscious cats. Br J Pharmacol (1974) 1.62
Development and evaluation of an ultrasonic ground water seepage meter. Ground Water (2001) 1.59
The mode of antifungal action of tolnaftate. J Med Vet Mycol (1986) 1.55
Phase I/II evaluation of nevirapine alone and in combination with zidovudine for infection with human immunodeficiency virus. J Acquir Immune Defic Syndr Hum Retrovirol (1995) 1.55
Mode of deactivation of the enkephalins by rat and human plasma and rat brain homogenates. Nature (1976) 1.52
Influence of gender, race, and education on patient preferences and receipt of cardiac catheterizations among coronary care unit patients. Am J Cardiol (1996) 1.36
Population pharmacokinetics of nevirapine, zidovudine, and didanosine in human immunodeficiency virus-infected patients. The National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group Protocol 241 Investigators. Antimicrob Agents Chemother (1999) 1.32
Sore throat pain in the evaluation of mild analgesics. Clin Pharmacol Ther (1988) 1.31
Antiviral effect and pharmacokinetic interaction between nevirapine and indinavir in persons infected with human immunodeficiency virus type 1. J Infect Dis (1999) 1.28
Zebrafish: an emerging technology for in vivo pharmacological assessment to identify potential safety liabilities in early drug discovery. Br J Pharmacol (2008) 1.28
Management of negative symptoms among patients with schizophrenia attending multiple-family groups. Psychiatr Serv (2000) 1.27
Patterns of compliance with once versus twice daily antihypertensive drug therapy in primary care: a randomized clinical trial using electronic monitoring. Can J Cardiol (1997) 1.26
Tissue levels of several radiolabelled beta-adrenoceptor antagonists after intravenous administration in rats. Arch Int Pharmacodyn Ther (1979) 1.25
Intracellular cytokine production by human CD4+ and CD8+ T cells from normal and immunodeficient donors using directly conjugated anti-cytokine antibodies and three-colour flow cytometry. Clin Exp Immunol (1996) 1.24
Comparison of the alpha-adrenoceptor antagonist profiles of idazoxan (RX 781094), yohimbine, rauwolscine and corynanthine. Naunyn Schmiedebergs Arch Pharmacol (1984) 1.21
A complete description of the EGF-receptor exon structure: implication in oncogenic activation and domain evolution. Oncogene (1993) 1.20
The cell polarity regulator hScrib controls ERK activation through a KIM site-dependent interaction. Oncogene (2010) 1.19
Induction of tissue transglutaminase in mouse peritoneal macrophages. J Biol Chem (1983) 1.17
Differential effects of prazosin on the pre- and postsynaptic alpha-adrenoceptors in the rat and dog [proceedings]. Br J Pharmacol (1977) 1.15
Effects of prazosin and phentolamine on cardiac presynaptic alpha-adrenoceptors in the cat, dog and rat. Clin Exp Hypertens (1978) 1.15
Characterization of the V0 domain of the coated vesicle (H+)-ATPase. J Biol Chem (1992) 1.15
An evaluation of methods to quantitate the chick chorioallantoic membrane assay in angiogenesis. Lab Invest (1985) 1.14
The alpha 2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cells. Eur J Pharmacol (1991) 1.14
Enzyme-linked immunosorbent assay for detection of antibody to varicella-zoster virus. J Clin Microbiol (1982) 1.13
Studies on the mechanism of the vasodilator effects of prazosin in dogs and rabbits. Eur J Pharmacol (1978) 1.13
Antiviral beta-L-nucleosides specific for hepatitis B virus infection. Antivir Chem Chemother (2001) 1.12
Macular corneal dystrophy in Iceland. A clinical, genealogic, and immunohistochemical study of 28 patients. Ophthalmology (1996) 1.12
Endometrial inhibin/activin beta-B subunit expression is related to decidualization and is reduced in tubal ectopic pregnancy. J Clin Endocrinol Metab (2008) 1.11
alpha 2-Adrenoceptor agonists induced mydriasis in the rat by an action within the central nervous system. Br J Pharmacol (1983) 1.11
Cardiovascular effects of beta-adrenoreceptor blocking agents after intracerebroventricular administration in conscious normotensive cats. Clin Exp Pharmacol Physiol (1975) 1.10
Human and primate tumour viruses use PDZ binding as an evolutionarily conserved mechanism of targeting cell polarity regulators. Oncogene (2008) 1.10
Human vascular smooth muscle cells express receptors for CC chemokines. Arterioscler Thromb Vasc Biol (1998) 1.09
Prophylaxis of varicella in children with neoplastic disease: comparative results with zoster immune plasma and gamma globulin. Cancer (1975) 1.08
Supracondylar femoral extension osteotomies in the treatment of fixed flexion deformity of the knee. Clin Orthop Relat Res (1983) 1.08
2-Amino-2-deoxygalacturonic acid in lipopolysaccharides from Pseudomonas aerugimosa. Biochem J (1975) 1.08
NGO initiatives in risk reduction: an overview. Disasters (2001) 1.08
Quantitation of corneal neovascularization using computerized image analysis. Lab Invest (1988) 1.06
Preliminary studies on SL 75212, a new potent cardioselective beta-adrenoceptor antagonist [proceedings]. Br J Pharmacol (1979) 1.06
16-Me cyprenorphine (RX 8008M): a potent opioid antagonist with some delta selectivity. Life Sci (1987) 1.06
The primordial follicle reserve is not renewed after chemical or γ-irradiation mediated depletion. Reproduction (2012) 1.03
Survival rates after enucleation of eyes with malignant melanoma. Am J Ophthalmol (1979) 1.03
The pharmacology of prazosin, a novel antihypertensive agent. Life Sci (1980) 1.03
Synthesis and biological evaluation of 14-alkoxymorphinans. 2. (-)-N-(cyclopropylmethyl)-4,14-dimethoxymorphinan-6-one, a selective mu opioid receptor antagonist. J Med Chem (1989) 1.02
Structure-activity relationships of methionine-enkephalin. J Pharm Pharmacol (1976) 1.01
Substituted 1,3,4-thiadiazoles with anticonvulsant activity. 3. Guanidines. J Med Chem (1987) 1.01
Antibodies to diabetes-associated autoantigens in Indian patients with Type 1 diabetes: prevalence of anti-ICA512/IA2 and anti-SOX13. Diabetes Res Clin Pract (2001) 1.00
Central adrenoreceptors and the control of arterial blood pressure. Clin Exp Pharmacol Physiol (1975) 1.00
Adrenoceptors in the central nervous system concerned with cardiovascular control. J Pharm Pharmacol (1972) 0.99
Chemokine production by human vascular smooth muscle cells: modulation by IL-13. Br J Pharmacol (1997) 0.99
Outcomes after aneurysm rupture during endovascular coil embolization. Neurosurgery (2001) 0.98
[3H]RX821002: a new tool for the identification of alpha 2A-adrenoceptors. Eur J Pharmacol (1989) 0.98
-Adrenergic receptors in the central nervous system of the cat concerned with control of arterial blood pressure and heart rate. Nat New Biol (1973) 0.98
Opiate receptors in the rat vas deferens. Life Sci (1983) 0.98
Proteoglycan biosynthesis by human corneas from patients with types 1 and 2 macular corneal dystrophy. J Biol Chem (1990) 0.97
Substituted 1,3,4-thiadiazoles with anticonvulsant activity. 2. Aminoalkyl derivatives. J Med Chem (1986) 0.97
Presynaptic alpha-adrenoreceptors; in vitro methods and preparations utilised in the evaluation of agonists and antagonists. J Auton Pharmacol (1980) 0.96
Smiling and fussing in seven-month-old preterm and full-term black infants in the still-face situation. Child Dev (1995) 0.96
Macular corneal dystrophy. Studies of sulfated glycosaminoglycans in corneal explant and confluent stromal cell cultures. Am J Pathol (1977) 0.96
Characterization of alpha-adrenoceptors in the vasculature of the canine nasal mucosa. Br J Pharmacol (1986) 0.95
Antihypertensive thiadiazoles. 1. Synthesis of some 2-aryl-5-hydrazino-1,3,4-thiadiazoles with vasodilator activity. J Med Chem (1988) 0.95
Caffeine as an analgesic adjuvant. A double-blind study comparing aspirin with caffeine to aspirin and placebo in patients with sore throat. Arch Intern Med (1991) 0.95
Expanded TcR V beta 5.1 family in a diffuse high-grade B cell immunoblastic lymphoma. Leukemia (1995) 0.94
Modification of cardiac Na+ channels by batrachotoxin: effects on gating, kinetics, and local anesthetic binding. Biophys J (1993) 0.94
T-cell receptor variable (V) gene usage by lymphoid populations in T-cell lymphoma. J Pathol (1992) 0.94
Substituted 1,3,4-thiadiazoles with anticonvulsant activity. 1. Hydrazines. J Med Chem (1986) 0.94
New 14-aminomorphinones and codeinones. NIDA Res Monogr (1988) 0.93
The development of a blood paracetamol estimation kit. J Int Med Res (1976) 0.93
Restenosis following angioplasty in the swine coronary artery is inhibited by an orally active PDGF-receptor tyrosine kinase inhibitor, RPR101511A. Circulation (1999) 0.93
The effects of prazosin on the clonidine induced hypotension and bradycardia in rats and sedation in chicks [proceedings]. Br J Pharmacol (1978) 0.92
Olfactory bulb removal eliminates maternal behavior in the mouse. Science (1971) 0.92
Time-course analysis of the cardiovascular effects of clonidine resulting from the activation of cardiac pre- and vascular postsynaptic alpha-adrenoceptors in the pithed rat [proceedings]. Br J Pharmacol (1978) 0.92
Subcellular localisation of leucine-enkephalin-hydrolysing activity in rat brain. Nature (1977) 0.91
Selectivity and potency of 2-alkyl analogues of the alpha 2-adrenoceptor antagonist idazoxan (RX 781094) in peripheral systems. Br J Pharmacol (1984) 0.91
Improved survival rates among testis cancer patients in the United States. JAMA (1982) 0.91
Alpha-adrenoreceptor reagents. 3. Synthesis of some 2-substituted 1,4-benzodioxans as selective presynaptic alpha 2-adrenoreceptor antagonists. J Med Chem (1985) 0.91